EKElena Valentinovna Kiseleva

Elena Valentinovna Kiseleva

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Elena Valentinovna Kiseleva has a total of 24 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Dysfunction of pancreatic β-cells as a factor in the development of prediabetes in adolescents with obesity during puberty

    by N.B. Minkova, O.YU. Latyshev, G.F. Okminyan, E.V. Kiseleva, D.S. Romaykina, L.N. Samsonova

    Нарушение функциональной активности панкреатических -клеток как фактор развития предиабета у детей с ожирением в пубертатном периоде

  • Open Access

    Insulin resistance and its role in the pathogenesis of pre-diabetes development in obese adolescents

    by Nadezhda B. Min'KOva, Oleg Iu. Latyshev, Goar F. Okminyan, Elena V. Kiseleva, Dar'IA S. Romaikina, Liubov N. Samsonova, Ромайкина Дарья Сергеевна

    Background. The prevalence of childhood obesity has increased significantly over the past three decades worldwide, and in this regard, the frequency of diseases associated with obesity, including disorders of carbohydrate metabolism, has increased. The involvement of insulin resistance and insulin deficiency in the development of prediabetes in obesity has been established. However, the significance of each pathological mechanism in the development of prediabetes in childhood and adolescence has not been established. In this regard, in children's practice, there is no reliable data on methods of prevention and treatment of prediabetes in obesity. Aim. To study the role of insulin resistance in the development of prediabetes in obese adolescents. Materials and methods. The study involved 95 adolescents with obesity. Inclusion criteria: SDS BMI≥2.0, Tanner stage ≥II, age 18.0 years, exclusion criteria: diabetes mellitus. The sample was divided into prediabetics (n=40, mean age 14.0±1.53 years; SDS BMI 3.09±0.54, boys n=23) and non-prediabetics (n=55, mean age 14.6±1.67 years; SDS BMI 3.11±0.54; boys n=32). Both groups were matched on age, SDS BMI, sex (p=0.082, p=0.975, p=0.947, respectively). The research consisted of estimates of BMI, insulin, C-peptide, fasting venous blood glucose, HbA1c, cholesterol, low-density lipoprotein, high Density Lipoprotein, triglycerides, alanine aminotransferase, aspartat aminotransferase, HOMA-IR and TyG indices, results of oral glucose tolerance test at 0 and 2 hours after glucose load, ultrasound of the hepatobiliary system. Prediabetes in adolescents was diagnosed using American Diabetes Association criteria. Data was analyzed by using SPSS Statistics for Windows, Version 26.0. Results. Prediabetes was diagnosed in 42.1% (40/95) of cases. There were statistically significant differences between the indices of groups with prediabetes and normal glucose metabolism: fasting plasma glucose – FPG (mean 5.63±0.49; 95% confidence interval – CI 5.48–5.79 vs 5.03±0.42; 4.92–5.15 mmol/L; p0.001); 2hPG (mean 7.04±0.93; 95% CI 6.74–7.34 vs 6.23±0.82; 6.01–6.46 mmol/l; p0.001); HbA1c (mean 5.5±0.31; 95% CI 5.39–5.59% vs 5.2±0.25; 5.15–5.29%; p0.001); cholesterol (4.47±0.73; 95% CI 4.23–4.72 vs 3.96±0.92; 3.73–4.24 mmol/l; p=0.004), low-density lipoprotein (2.89±0.96, 95% CI 2.55–3.20 vs 2.46±0.89, 2.21–2.71 mmol/l; p=0.036). There were no significant differences in fasting insulin, C-peptide, triglycerides, high density lipoprotein, aspartat aminotransferase, alanine aminotransferase, HOMA-IR index and TyG, were also no significant differences in the frequency of hepatic steatosis (47.5% vs 52.7%; p=0.532). Conclusion. Teenagers with obesity, with prediabetes, and without disorders of carbohydrate metabolism had a similar level of peripheral tissue sensitivity to the action of insulin. There are additional factors leading to the formation of prediabetes with obesity in the child population that have to be learned in future researches.


  • Disorders of sex development: the current state of the problem (lecture)

    by Moscow Russian Medical Academy Of Continuing Medical Education Of Ministry Of Healthcare Of The Russian Federation, E.A. Volod`kO, O.YU. Latyshev, A.B. Okulov, D.N. Brovin, E.V. Kiseleva, G.F. Okminyan, K.D Sangare, A.V. Anikiev, L.N. Samsonova

    Нарушение формирования пола: современное состояние проблемы (лекция)

  • Thyroid hormone resistance syndrome in a 12-year-old girl: clinical case description

    by D.S. Romaykina, A.A. Matveeva, Moscow Russian Medical Academy Of Continuing Professional Education Of The Ministry Of Healthcare Of The Russian Federation, G.F. Okminyan, E.V. Kiseleva, L.N. Samsonova

    Синдром резистентности к тиреоидным гормонам у 12-летней девочки: описание клинического случая

  • Flash glucose monitoring in the practice of pediatric endocrinologist

    by G.F. Okminyan, Russian Medical Academy Of Continuing Professional Education, E.V. Kiseleva, O.Yu. Latyshev, E.P. Kasatkina, L.N. Samsonova


  • Basal insulin evolution: from simple to more complex

    by Russian Medical Academy Of Continuing Professional Education, G.F. Okminyan, O.YU. Latyshev, E.V. Kiseleva, E.P. Kasatkina, L.N. Samsonova

    Эволюция препаратов базального инсулина: от простого к сложному


  • Open Access

    The differential diagnosis of constitutional delay of puberty and hypogonadotropic hypogonadism in boys

    by Oleg Yurevich Latyshev, Lubov Borisovna Brzhezinskaya, Goar Feliksovna Okminyan, Elena Valentinovna Kiseleva, Mikhail Ivanovich Pykov, Elvira Petrovna Kasatkina, Lubov Nikolaevna Samsonova

    Backgraund: The problem of differential diagnosis of constitutional delay of puberty/CPD and hypogonadotropic hypogonadism/HH in boys is discussed, as boys have similar genetic mechanisms and appearance. Aims: to determine accuracy of the criteria for the differential diagnosis of CDP and HH. Materials: The study included 56 boys14,40,7 years old with delayed puberty (G1P1-3/testicular volume 3сm3). We excluded patients with hypergonadotropic hypogonadism, treated with sex steroids or gonadotropins for 12 months, with endocrine/somatic diseases affecting puberty. At the first visit, we evaluated anthropometric data, bone age, testicular volume, hormones and the results of the gonadotropin-releasing hormone test/GnRH agonist test and the human chorionic gonadotropin test/hCG test. The HH was defined by a testicular volume 3сm3 after 2 years follow-up. The patients were divided into two groups: the first group with CDP and testicles 3cm3 (n=50) and the second group with HH and testicles 3cm3 (n=6). Results: At the first visit in boys with CDP corrected target height was less (Me SDS -1,8 vs -0,4, р=0,02), bone age was less (Ме SDS -2,5 vs - 0,2 р=0,03), testicular volume was more (Ме 1,9 vs 0,5, p=0,0003), hormones were significantly higher, such as, LH (Ме 1,1 vs 0,1mIU/ml, p=0,0002), FSH (Ме 1,9 vs 0,2IU/l, p=0,00007), inhibinB (Ме 142,3 vs 31,3pg/ml, p=0,00009), maxLH (Ме 18,9 vs 0,6mIU/ml, p=0,00007), maxLH/FSH (Ме 2,3 vs 0,4, p=0,0002) on the GnRH agonist test and testosterone (Ме 14,4 vs 1,1nmol/l, p=0,0001) on the hCG test than in boys with HH. The LH 0,3 mIU/ml had 86% sensitivity, 100% specificity; maxLH/FSH1- 92% sensitivity, 100% specificity; testosterone 2,7 nmol/l on the hCG test - 98% sensitivity, 100% specificity for differential diagnosis of CDP and HH in boys. However, maxLH 3,5 mIU/ml on the GnRH agonist test, FSH 0,5 IU/l, inhibinB 58 pg/ml had 100% sensitivity and specificity for diagnosis of CDP. Conclusions: The inhibinB 58 pg/ml, LH 0,3 mIU/ml, FSH 0,5 IU/l or maxLH 3,5 mIU/ml, maxLH/FSH 1,0 on the GnRH agonist test, testosterone 2,7 nmol/l on the hCG test have an excellent accuracy for the differential diagnosis of CDP and HH in prepubertal boys with delayed puberty.


  • Puberty delay in girls: analyses of disease structure depending on clinical characteristics

    by Russian Medical Academy Of Continuing Professional Education, K.L. Kabolova, L.N. Samsonova, O.Yu. Latyshev, E.V. Kiseleva


  • Current tendencies in treatment of congenital hypogonadotropic hypogonadism in boys: clinical cases’ analysis

    by O.Yu. Latyshev, Russian Medical Academy Of Continuing Professional Education, E.V. Kiseleva, G.F. Okminyan, K.D. Kokoreva, L.N. Samsonova, E.P. Kasatkina

    Current tendencies in treatment of congenital hypogonadotropic hypogonadism in boys: clinical cases’ analysis


  • Open Access

    De la Chapelle syndrome: clinical and laboratory characteristics of 4 patients

    by Ekaterina S. Sannikova, Oleg Yu. Latyshev, Lubov N. Samsonova, Elena V. Kiseleva, Goar F. Okminyan, Elvira P. Kasatkina

    We describe 4 cases of 46,XX testicular disorder of sex development. Depending on the presence of the SRY gene, two variants of this disease are distinguished: SRY-positive and SRY-negative ones. The SRY (sex-determining region Y) gene is involved in differentiation of Sertoli cells and development of the testes. The pathogenesis of the disease in SRY-positive patients is related to translocation of the SRY gene from the Y chromosome to the X chromosome. The pathogenesis of the disease in SRY-negative patients is associated with overexpression of genes (SOX9, SOX3, etc.) responsible for the development of male genitalia or inadequate gene expression (WNT4, RSPO1, etc.) responsible for the development of female genitalia. The patients had a hermaphroditic genital structure with a masculinization score (EMS) of 6 and 11 and were SRY-negative in 50% of cases; 50% of the patients were SRY-positive with full masculinization, microorchidism, and gynecomastia. All children underwent a hormonal examination in the neutral and pubertal periods. Patients who reached pubertal age developed partial and total hypergonadotropic hypogonadism. The patients have had no need in substitution therapy with testosterone. One of the patients underwent a semiological analysis that revealed necrozoospermia and oligoasthenoteratozoospermia. A SRY-negative patient with cryptorchidism underwent biopsy of the cryptorchid gonad; no Leydig cells were found.